947 reports of this reaction
1.6% of all CAFFEINE CITRATE reports
#1 most reported adverse reaction
PEMPHIGUS is the #1 most commonly reported adverse reaction for CAFFEINE CITRATE, manufactured by Hikma Pharmaceuticals USA Inc.. There are 947 FDA adverse event reports linking CAFFEINE CITRATE to PEMPHIGUS. This represents approximately 1.6% of all 60,859 adverse event reports for this drug.
Patients taking CAFFEINE CITRATE who experience pemphigus should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PEMPHIGUS is a less commonly reported adverse event for CAFFEINE CITRATE, but still significant enough to appear in the safety profile.
In addition to pemphigus, the following adverse reactions have been reported for CAFFEINE CITRATE:
The following drugs have also been linked to pemphigus in FDA adverse event reports:
PEMPHIGUS has been reported as an adverse event in 947 FDA reports for CAFFEINE CITRATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PEMPHIGUS accounts for approximately 1.6% of all adverse event reports for CAFFEINE CITRATE, making it one of the most commonly reported side effect.
If you experience pemphigus while taking CAFFEINE CITRATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.